Dementia

A drug to treat Alzheimer’s disease was approved by the Food & Drug Administration. While it is not a cure, researchers at the University of Michigan are optimistic about what this could mean for patients and their loved ones. WEMU’s Josh Hakala reports.

The U.S. Food and Drug Administration, this month, granted accelerated approval to an Alzheimer’s drug that might slow the acceleration of memory loss for early-stage Alzheimer’s patients. But neurologist Dr. Judy Heidebrink at Michigan Alzheimer’s Disease Center at University of Michigan Health is looking at this drug with caution. WEMU’s Cathy Shafran brings us an in-depth discussion with Dr. Heidebrink about local hopes for the drug Lecanemab.

For the second year, the "Big Hearts For Seniors" event, which supports five community-supported programs of Michigan Medicine that serve older adults, is…

As a caregiver, dealing with someone experiencing dementia can be challenging.The Eastern Michigan University Aging Studies program is bringing in a…

Living with Alzheimer's Disease and other forms of dementia makes life difficult for older people and their family members. One life aspect that suffers…

This week, Art and Soul is about the performing arts. 89.1 WEMU’s Lisa Barry is joined by Jenn McKee and the artistic director of Kickshaw Theatre in Ann…

June is National Alzheimer's Awareness Month. It's a disease that affects more than 5.3 million individuals in the United States, and Washtenaw County is…

A new treatment procedure developed in Michigan can handle the most disturbing symptoms of dementia with the use of fewer drugs. A comprehensive approach…